Document is current
Any future updates will be listed below
-
Authors
Herman, Joseph L.
Dornbos, Peter
Landheer, Karl https://orcid.org/0000-0001-5012-3007
Geraghty, Benjamin J.
Egerman, Marc A.
Phan, Duc
Germino, Mary
Mastaitis, Jason W. https://orcid.org/0000-0002-9991-3509
Walls, Johnathon R.
Lotta, Luca A. https://orcid.org/0000-0002-2619-5956
Abecasis, Gonçalo https://orcid.org/0000-0003-1509-1825
Baras, Aris https://orcid.org/0000-0002-6830-3396
Altarejos, Judith Y. https://orcid.org/0000-0003-2764-6074
Sleeman, Mark W.
,
Melander, Olle
,
Shavlakadze, Tea
Yancopoulos, George D.
Bovijn, Jonas https://orcid.org/0000-0001-7436-4446
Marchini, Jonathan https://orcid.org/0000-0003-0610-8322
Glass, David J. https://orcid.org/0000-0001-6187-4164
-
Funding
Funding for this research was provided by:
Regeneron Pharmaceuticals funded this study
- License Information
-
More Information
Article History
Received: 1 April 2025
Accepted: 26 February 2026
First Online: 13 March 2026
Competing interests
: Authors listed with Regeneron affiliations are Regeneron employees, and many of them hold stock in the company. The remaining author declares no competing interests.
